Neogen Corporation is recalling approximately 3,900 bottles of Thyrocryn and ThyroKare (levothyroxine sodium tablets), USP, 1.0 mg, used to treat hypothyroidism in dogs. The recall was initiated because testing showed the tablets are subpotent, meaning they contain less of the active ingredient than required. The affected products were sold in 180-count and 1,000-count bottles across several states including Florida, Texas, and New York. To date, no injuries or adverse health events have been reported in connection with these products.
Low potency medication can lead to under-treatment of a dog's thyroid condition. If a dog does not receive the intended dose of levothyroxine sodium, their hypothyroid symptoms may not be properly managed or could return.
You have 2 options:
Manufactured for Aspen Veterinary Resources, LTD; NADA 141-539
Manufactured by Neogen Corporation; NADA 141-539
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response